The Obstacles That Are Faced Due to Singling Out Human Epidermal Growth Factor Receptor 2 (HER2) in Endometrial Carcinoma
In the United States, over 50,000 women get diagnosed with endometrial cancer every year, making...
Read More
Hematology/Oncology
The risk of distant metastases in patients with gynecologic cancers after surgery: a population-based study.
The aim of the study was to determine the risk of distant metastases in patients with gynecologic...
Read More
Minimally Invasive Robotic Surgery for Early-Stage Endometrial Cancer on a National Scale and Its Relationship to Severe Complications
When compared to a total abdominal hysterectomy, minimally invasive laparoscopic surgery (MILS)...
Read More
Prediagnostic Experiences of Black Women in the United States With Endometrial Cancer
Endometrial cancer kills black women 90% more than white women. The advanced disease stage at...
Read More
The Relationship Between Neoadjuvant Chemotherapy and Overall Survival in Women With Metastatic Endometrial Cancer
Although primary debulking surgery (PDS) is frequently regarded as the gold standard for stage IV...
Read More
Endometrial Cancer Risk is Associated With Racial/Ethnic Disparities in Anthropometric And Hormone-Related Variables
Although anthropometric and hormone-related variables are well-established endometrial cancer risk...
Read More
Endometrial Cancer Therapy With Synthetically Deadly Nanoparticles
One of the most aggressive kinds of endometrial cancer, uterine serous carcinoma, is distinguished...
Read More
A Randomized Study of Medroxyprogesterone Acetate to Prevent Endometrial Pathology from Adjuvant Tamoxifen for Breast Cancer was Conducted
Adjuvant tamoxifen’s proliferative impact on the endometrium has the potential to cause...
Read More
By Altering Metabolism and Increasing Hypoxia Tolerance, Mitochondrial Supercomplex Formation Promotes Breast and Endometrial Cancer
A recent breakthrough in cancer research throws insight into the role of mitochondrial respiration...
Read More
Endometrial Cancer Patients’ Plasma Exosomes Contain LGALS3BP, which Promotes Endometrial Cancer Development
Endometrial cancer (EC) is the most frequent gynecological cancer in the world. Exosomes, which...
Read More
Microsatellite Instability with Little Microsatellite Shift Increased Risk of Endometrial Cancer
Mismatch-repair deficiency testing is crucial for the identification of probands in Lynch Syndrome...
Read More
Oncogenic LIF/LIFR Signaling is a New Therapeutic Target in Endometrial Cancer
The fourth most frequent disease in women is endometrial cancer (EC). The therapy choices for...
Read More
In Type I Endometrial Carcinomas, ALDH1 Expression Predicts The Development of Premalignant Lesions To Malignancy
Unopposed estrogen stimulation is hypothesized to cause endometrial hyperplasia, which precedes...
Read More
Normal Human Endometrial Epithelium’s Mutational Landscape
Although it is assumed that all normal somatic cells acquire mutations, knowledge of the rates,...
Read More
The Levels of Sex Hormones in Type 1 and Type 2 Endometrial Cancer are Not Different
The role of hormonal variables in the development of endometrial cancer is well established....
Read More
In Endometrial Cancer, Pterostilbene, a Natural Phenolic Molecule, Enhances the Antineoplastic Actions of Megestrol Acetate
Endometrial cancer is the most prevalent gynecologic cancer in the United States, and its...
Read More
Endometrial Cancer MSH3 Mutation and Evidence for its Functional Significance in Heteroduplex Repair
The lengths of repeated sequence segments in several human tumors have changed. Although mutations...
Read More
Endometrial Cancer Radiosensitivity is Reduced by Exosomal Transfer of Tumor-Associated Macrophage-Derived hsa_circ_000161
Radioresistance is a clinical barrier to endometrial cancer (EC) therapy and causes tumor...
Read More
Patients Suffering From Deteriorating Oestrogen Receptor-Positive Ovarian Cancer or Endometrial Cancer Underwent a Second Phase Clinical Trial of Ribociclib and Letrozole
In order to treat relapsed estrogen receptor (ER)-positive ovarian cancer (OC) and endometrial...
Read More
Patients Suffering from Non-Metastatic Colorectal and Endometrial Cancer May Encounter Mismatch Repair Deficiency’s Prognostic Ramifications
It is indistinct how clinically significant mismatch repair (MMR) status is in patients who are...
Read More